SCHEMBL7365612

SCHEMBL7365612

Cc1ccc(S(=O)(=O)N(CC(=O)O)C(C)c2cccs2)cc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DAGLA Q9Y4D2 1/20 0.48
RAB9A P51151 1/20 0.48
KEAP1 Q14145 2/20 0.48
NFE2L2 Q16236 2/20 0.48
MMP1 P03956 2/20 0.44
MMP2 P08253 2/20 0.44
MMP9 P14780 2/20 0.44
MMP8 P22894 2/20 0.44
MMP14 P50281 2/20 0.44
POLB P06746 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
ALOX5 P09917 1/20 0.43
TP53 P04637 1/20 0.42
MMP3 P08254 1/20 0.42
MMP13 P45452 1/20 0.42
MMP16 P51512 1/20 0.42
ADAM17 P78536 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5569734 0.81 CA1 (0.44) MMP9POLBTDP1TP53
SCHEMBL19471016 0.81 DAGLA (0.70) DAGLAKEAP1NFE2L2MMP1MMP2
SCHEMBL17674720 0.81 DAGLA (0.70) DAGLAKEAP1NFE2L2MMP1MMP2
SCHEMBL8606887 0.76 KEAP1 (0.57) DAGLAKEAP1NFE2L2MMP1MMP2
SCHEMBL8608129 0.76 KEAP1 (0.57) DAGLAKEAP1NFE2L2MMP1MMP2
SCHEMBL8606884 0.76 KEAP1 (0.57) DAGLAKEAP1NFE2L2MMP1MMP2
SCHEMBL28352267 0.74 DAGLA (0.55) DAGLAKEAP1NFE2L2MMP1MMP2
SCHEMBL11470887 0.73 KEAP1 (0.52) DAGLAKEAP1NFE2L2MMP1MMP2
SCHEMBL5297763 0.71 MMP2 (0.57) DAGLAKEAP1NFE2L2MMP1MMP2
SCHEMBL7365613 0.71 CNR2 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001973-A1 COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP disclosed
WO-1999006433-A1 COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed